ProfileGDS5678 / 1416144_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.175699
GSM967853U87-EV human glioblastoma xenograft - Control 211.27199
GSM967854U87-EV human glioblastoma xenograft - Control 311.49399
GSM967855U87-EV human glioblastoma xenograft - Control 410.90299
GSM967856U87-EV human glioblastoma xenograft - Control 510.880399
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.41699
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.097799
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.821599
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.749199
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.186699
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.055799
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.201899
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.979399
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.125599